Cipher Pharmaceuticals Inc. CPH

Updated: 10 Aug 2026

TSX | Biotech | Specialty Pharmaceuticals

No signal published yet

We already track Cipher Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Cipher Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
TSX
Type
Biotech
Sector
Specialty Pharmaceuticals
We're already tracking Cipher Pharmaceuticals Inc. — here are the latest events we've registered

Recent News

  • On July 6, 2026, Cipher Pharmaceuticals announced it signed a letter of intent with the pan-Canadian Pharmaceutical Alliance regarding public drug plan coverage for Epuris in Canada. On July 31, 2026, the company announced that it will release its second-quarter 2026 financial results on August 11, 2026.

What Firelda Watch includes for Cipher Pharmaceuticals Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Cipher Pharmaceuticals Inc. will be delivered in the same format.

Want to follow Cipher Pharmaceuticals Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Cipher Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Cipher Pharmaceuticals Inc. CPH
Cipher Pharmaceuticals — follow and we'll monitor it
Follow Cipher Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.